| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.04 |
| mRNA | gossypol | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | nakiterpiosin | CTRPv2 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.075 | 0.05 |
| mRNA | VX-11e | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |